31 Mar 2023
Assets13.69
Total Income7.19
EBITDA1.52
Profit After Tax1.06
NET Worth1.99
Reserves and Surplus1.29
Total Borrowing5.25
At a glance
Updated 2026-08-24Asston Pharmaceuticals is a SME IPO with an issue size of ₹27.56 crore, proposed for listing on BSE SME. The offer opens on 9th Jul 2025 and closes on 11th Jul 2025. The issue structure includes a fresh issue of ₹26.17 crore.
Issue details
Listing atBSE SME
Issue typeBook Build Issue
Issue size₹27.56 Cr
Fresh issue₹26.17 Cr
Face value₹10
Price band₹115.00–₹123.00
Allotment14th Jul 2025
Listing16th Jul 2025
Grey market
GMP page ↗Latest GMP₹26.00
GMP / upper price21.14%
Est. listing₹149.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens9th Jul 2025
Closes11th Jul 2025
Allotment14th Jul 2025
Refund15th Jul 2025
Demat15th Jul 2025
Listing16th Jul 2025
Subscription demand
Full bidding ↗Total186.55×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 2000 | ₹246,000 |
Company
Incorporated2019
Use of proceeds
| Object | Amount |
|---|---|
| Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit | ₹6.00 Cr |
| Funding the incremental working capital requirements of the Company | ₹13.00 Cr |
| Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company | ₹1.00 Cr |
| General Corporate Purposes | ₹3.95 Cr |
| Issue Expenses | ₹3.61 Cr |
| Total | ₹27.56 Cr |
Financials
Full financials ↗31 Mar 2024
Assets20.26
Total Income15.84
EBITDA2.55
Profit After Tax1.36
NET Worth6.39
Reserves and Surplus5.61
Total Borrowing6.82
31 Mar 2025
Assets28.12
Total Income25.61
EBITDA6.16
Profit After Tax4.33
NET Worth10.72
Reserves and Surplus4.45
Total Borrowing7.26
31 May 2025
Assets31.83
Total Income6.21
EBITDA1.93
Profit After Tax1.32
NET Worth12.04
Reserves and Surplus5.77
Total Borrowing7.83
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 50.56% |
| ROCE | 51.25% |
| Debt / Equity | 0.68% |
| RoNW | 40.36% |
| PAT Margin | 17.27% |
| EBITDA Margin | 24.60% |
| Price to Book Value | 12.07 |
Valuation & shareholding
Pre-IPO EPS6.90
Post-IPO EPS9.32
Pre-IPO P/E17.83
Post-IPO P/E13.2
Promoter holding pre68.76%
Promoter holding post50.66%
Market cap₹104.70 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit | ₹6.00 Cr |
| Funding the incremental working capital requirements of the Company | ₹13.00 Cr |
| Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company | ₹1.00 Cr |
| General Corporate Purposes | ₹3.95 Cr |
| Issue Expenses | ₹3.61 Cr |
| Total | ₹27.56 Cr |
Registrar & lead managers
Registrar
Maashitla Securities Pvt.Ltd.Lead managers
- Sobhagya Capital Options Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.